Internal Medicine, Nephrology · Lakewood, CA
NPI
1083649735
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
3650 South St, Suite 101
Lakewood, CA, 90712
Phone (562) 286-6466
Groups this clinician bills Medicare through
Medicare paid, 2024
$613K
5,423 services
Medicare patients, 2024
862
Average age 74
Drug cost, 2024
$2.0M
7,288 prescriptions
Company payments, 2025
$642
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kyaw Moe was code 99232 (hospital e&m - subsequent), 1,997 times for 379 patients. In total Kyaw Moe billed 5,423 services in 22 codes, and Medicare paid $613K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,997 | 379 | $67.25 | $134K |
| 99214 Office E&M - Established | Office | 1,255 | 380 | $106.94 | $134K |
| 99233 Hospital E&M - Subsequent | Facility | 920 | 273 | $101.47 | $93K |
| 90960 ESRD Related Services (not dialysis) | Office | 418 | 66 | $305.38 | $128K |
| 99223 Hospital E&M - Initial | Facility | 316 | 291 | $147.37 | $47K |
| 90935 Hemodialysis | Facility | 99 | 75 | $60.67 | $6,006 |
| 99291 Critical Care E&M | Facility | 98 | 33 | $180.05 | $18K |
| 99204 Office E&M - New | Office | 57 | 57 | $140.45 | $8,006 |
| 90961 ESRD Related Services (not dialysis) | Office | 51 | 31 | $255.05 | $13K |
| 99222 Hospital E&M - Initial | Facility | 49 | 43 | $111.54 | $5,466 |
| 99213 Office E&M - Established | Office | 31 | 26 | $78.89 | $2,446 |
| 99214 Office E&M - Established | Facility | 24 | 16 | $83.69 | $2,009 |
| 99215 Office E&M - Established | Facility | 12 | 12 | $120.63 | $1,448 |
By year: 2022 $537K for 4,487 services; 2023 $586K for 4,922 services; 2024 $613K for 5,423 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kyaw Moe prescribed most often to Medicare patients was Allopurinol, with 763 prescriptions and refills. In total Kyaw Moe wrote 7,288 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Allopurinol Generic | 763 | 1,901 | 235 | $7,741 |
| Rosuvastatin Calcium Generic | 497 | 1,196 | 157 | $7,750 |
| Farxiga Dapagliflozin Propanediol | 389 | 691 | 98 | $361K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 354 | 749 | 93 | $3,622 |
| Jardiance Empagliflozin | 349 | 603 | 83 | $338K |
| Bumetanide Generic | 328 | 577 | 89 | $6,525 |
| Losartan Potassium Generic | 325 | 724 | 114 | $1,946 |
| Hydralazine Hcl Generic | 285 | 491 | 89 | $2,512 |
| Kerendia Finerenone | 235 | 348 | 45 | $214K |
| Amlodipine Besylate Generic | 227 | 495 | 75 | $980 |
| Rybelsus Semaglutide | 225 | 302 | 48 | $268K |
| Metoprolol Succinate Generic | 209 | 447 | 71 | $2,678 |
| Carvedilol Generic | 202 | 420 | 62 | $1,733 |
| Febuxostat Generic | 195 | 346 | 46 | $18K |
| Calcitriol Generic | 174 | 308 | 54 | $2,601 |
Brand drugs: - claims; generic drugs: 5,349 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kyaw Moe $642 ($642 in general payments such as food, travel and fees) from 12 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $262.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $262 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $85.68 |
| Aurinia Pharma U.S., Inc. AUPH | 3 | $66.13 |
| Abiomed JNJ | 1 | $31.44 |
| Amgen Inc. AMGN | 1 | $28.57 |
| Calliditas Therapeutics US Inc. | 1 | $28.54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25.99 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $25.59 |
| Vifor Pharma, Inc. | 1 | $25.24 |
| Akebia Therapeutics Inc AKBA | 1 | $24.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.